![]() |
市場調查報告書
商品編碼
2121854
細菌生物農藥:市場佔有率分析、產業趨勢與統計、成長預測(2026-2031)Bacterial Biopesticides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
根據 Mordor Intelligence 預測,細菌生物農藥的市場規模預計將從 2025 年的 27.5 億美元成長到 2026 年的 31.5 億美元,並將從 2026 年到 2031 年以 14.70% 的複合年成長率成長,到 2031 億美元。

本報告按產品類型(蘇力菌、枯草芽孢桿菌、螢光假單胞菌及其他)、施用方法(葉面噴布、種子處理及其他)、作物類型(穀類、油籽、豆類及其他)和地區(北美、歐洲、亞太、南美、非洲)進行細分。市場預測以美元計價。
歐洲生物農藥的核准流程已從九年縮短至約三年,清理了超過100種未處理的積壓申請。歐盟委員會計劃於2025年實施新的歐盟法規,並在第四季最佳化生物農藥的核准流程。 2026年的《生物技術法案》將著重填補當前的監管空白。巴西也取得了類似的進展,包括批准了一種源自去活化伯克氏菌的生物農藥產品。美國環保署(EPA)正在清理根據《聯邦殺蟲劑、殺菌劑和滅鼠劑法案》(FIFRA)積壓的申請。這些監管變化將擴大註冊機會,降低合規成本,並使中小企業能夠進入細菌生物農藥市場。
研究表明,合成農藥造成的生物多樣性喪失和土壤劣化正在影響高階零售管道的購買決策。麻省理工學院2025年的研究顯示,全球31%的農業土壤面臨農藥污染的高風險。北美和歐洲的零售商正在實施嚴格的殘留標準,並優先考慮零殘留生物來源產品。隨著生產者適應這些要求,細菌製劑已從單純的有機農業解決方案發展成為綜合蟲害管理(IPM)方案的重要組成部分。這種轉變正在推動細菌生物農藥市場的成長,尤其適用於收穫間隔期較短的作物。
由於孢子製劑通常在高於 25 度C的溫度下失去活性,因此需要冷藏運輸和冷藏保管,這推高了最終成本。在赤道市場,由於小規模分銷網路中溫控儲存設施稀缺,這項挑戰尤其嚴峻。雖然新的包封技術正在提高室溫下的細胞活性並緩解分銷限制,但擴大生產規模和獲得監管部門批准需要多個生長季。這些物流限制阻礙了市場滲透,並削弱了細菌生物農藥與保存期限更長、儲存要求更低的化學農藥之間的競爭。
預計到2025年,Bt將佔銷售額的73.60%,繼續保持其在細菌生物農藥市場的主導地位。其市場主導地位歸功於其對鱗翅目幼蟲的靶向毒性、廣泛的有機認證以及全球監管機構的批准。由於新型包封技術的出現,提高了Bt產品在高紫外線(UV)條件下的田間持久性,預計Bt產品的市場規模將進一步擴大。 2024年的研究證實,Bt毒素對鱗翅目、甲蟲、半翅目、雙翅目和線蟲害蟲均有效。
枯草桿菌(Bacillus subtilis)尤其在高價值園藝領域展現出巨大的成長潛力,年複合成長率高達16.50%,這得益於其兼具病害控制和促進植物生長的雙重優勢。螢光假單胞菌(Pseudomonas fluorescens)已確立其在控制土壤傳播病原菌方面的作用,而沙雷氏菌屬(Serratia)和鏈黴菌屬(Streptomyces)的菌種因其幾丁質酶活性和產生抗生素代謝物的能力而備受關注,並有望應用於特定領域。
北美將繼續佔據主導地位,預計2025年將佔全球銷售額的37.50%。在美國,大規模玉米和大豆種植中廣泛採用細菌製劑是推動市場規模成長的主要因素。在加拿大,溫室叢集透過使用與水耕施肥和灌溉系統相容的液體接種劑,正在提升當地需求。 2023年,加拿大920家商業溫室蔬菜種植設施共生產了802,163噸蔬菜,比2022年增加了7%。
亞太地區呈現最強勁的成長勢頭,預計2031年年複合成長率(CAGR)將達到17.40%。中國的「五年生物防治規劃」和印度的生物投入補貼計畫正在推動國內生產和應用。日本和新加坡的垂直農業企業為專為可控環境農業開發的液體製劑提供了成熟的市場。
儘管歐洲對生物農藥仍實施嚴格的監管,但近期監管政策的調整加速了其應用。歐盟委員會的《2025快速通道法規》縮短了申請審查時間,並使其與北美標準接軌。這將有助於更多產品註冊,並鼓勵製造商在歐盟範圍內擴大產品標籤範圍。斯堪的斯堪地那維亞學校膳食的公共採購政策以及德國「從農場到餐桌」計劃中農藥減量目標,都推動了對生物農藥的需求成長,尤其是含有蘇雲金芽孢桿菌(Bt)和枯草芽孢桿菌(B. subtilis)的葉面噴布產品。東歐穀物生產商也開始測試基於芽孢桿菌的種子處理方法,以符合出口市場更嚴格的殘留限量要求,其應用範圍已擴展到傳統的高價值園藝領域之外。
According to Mordor Intelligence, the bacterial biopesticides market size is expected to grow from USD 2.75 billion in 2025 to USD 3.15 billion in 2026 and is forecast to reach USD 6.26 billion by 2031 at 14.70% CAGR over 2026-2031.

This report is Segmented by Product Type (Bacillus Thuringiensis, Bacillus Subtilis, Pseudomonas Fluorescens, and Other Types), Mode of Application (Seed Treatment, Foliar Spray, and More ), Crop Type (Grains and Cereals, Oilseeds and Pulses, and More), and Geography (North America, Europe, Asia-Pacific, South America, and Africa). The Market Forecasts are Provided in Terms of Value (USD).
The European approval process for biopesticides has reduced from nine years to approximately three years, addressing a backlog of over 100 pending substances. The European Commission intends to implement new EU regulations in 2025 to optimize biopesticide approval processes by Q4. The 2026 Biotech Act will focus on filling current regulatory gaps. Brazil has demonstrated similar progress by approving bio-insecticidal products derived from inactivated Burkholderia cells. The United States Environmental Protection Agency (EPA) is reducing application backlogs under FIFRA (Federal Insecticide, Fungicide, and Rodenticide Act). These regulatory changes expand registration opportunities, reduce compliance costs, and enable smaller companies to enter the bacterial biopesticides market.
Research demonstrating biodiversity loss and soil degradation from synthetic pesticides influences purchasing decisions in premium retail channels. A 2025 Massachusetts Institute of Technology study revealed that 31% of global agricultural soils faced high risks from pesticide contamination. North American and European retailers implement strict residue limits, favoring zero-residue biological products. As growers adapt to these requirements, bacterial agents have evolved from organic-only solutions to essential components of integrated pest management programs. This transition drives growth in the bacterial biopesticides market, especially for crops with short pre-harvest intervals.
Live spore formulations typically lose viability at temperatures above 25°C, necessitating refrigerated transport and storage, which increases the final cost. This challenge is particularly significant in equatorial markets where small-scale distribution networks lack temperature-controlled storage facilities. While new encapsulation technologies are improving cell viability at room temperature and reducing distribution constraints, the processes for scale-up and regulatory approval require multiple growing seasons. These logistical limitations restrict market penetration, reducing the competitiveness of bacterial biopesticides against chemical pesticides that offer extended shelf life and minimal storage requirements.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Bt accounted for 73.60% of 2025 revenue, maintaining its dominant position in the bacterial biopesticides market. This market leadership stems from its targeted toxicity against lepidopteran larvae, extensive organic certifications, and regulatory acceptance worldwide. The market size for Bt products is projected to expand due to new encapsulation technologies that improve field persistence in high-UV conditions. A 2024 study confirmed Bt toxins' effectiveness against lepidopteran, coleopteran, hemipteran, dipteran, and nematode pests.
Bacillus subtilis shows strong growth potential with a projected 16.50% CAGR, driven by its dual benefits of disease suppression and plant growth promotion, particularly in high-value horticulture. Pseudomonas fluorescens has established its role in controlling soil-borne pathogens, while Serratia and Streptomyces species are gaining traction in specialized applications through their chitinase activity and antibiotic metabolite production capabilities.
North America maintained its dominant position with a 37.50% share of the 2025 global revenue. The United States drives market volumes through widespread integration of bacterial solutions in large-scale corn and soybean operations. Canadian greenhouse clusters strengthen regional demand by utilizing liquid inoculants compatible with hydroponic fertigation systems. In 2023, Canada's 920 commercial greenhouse vegetable operations produced 802,163 metric tons of vegetables, a 7% increase from 2022.
Asia-Pacific demonstrates the strongest growth trajectory with an anticipated 17.40% CAGR through 2031. China's five-year green pest-control plan and India's bio-input subsidy programs encourage domestic production and adoption. Japan and Singapore's vertical farming operations provide established markets for liquid formulations specifically developed for controlled environment agriculture.
Europe maintains strict regulations for biopesticides, though recent changes have accelerated their adoption. The European Commission's 2025 fast-track regulation reduced dossier review times to align with North American standards, enabling more product registrations and encouraging manufacturers to expand their EU product labels. The demand for biopesticides has increased through Scandinavian public procurement policies for school meals and Germany's Farm-to-Fork pesticide reduction targets, particularly benefiting Bt and B. subtilis foliar products. Eastern European grain producers have initiated Bacillus-based seed treatment trials in response to export markets' stricter residue requirements, expanding beyond traditional high-value horticultural applications.